Immunization Schedules: Best Available Evidence for 2020
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years, with variations in vaccination rates.
A modest but long-lasting protective effect was observed, but full protection not achieved.
Between October 20, 2017 and February 20, 2018, the Vaccine Adverse Event Reporting System (VAERS) received 155 reports involving RZV, with 13 (8%) involving an administrative error.
CDC voted for Shingrix over Zostavax as herpes zoster vaccine of choice
More than 99% of immunocompetent persons aged 40 years and older have evidence of VZV infection and are susceptible to herpes zoster or shingles.
Risk of stroke and myocardial infarction may be more than double in the first week following a shingles diagnosis in elderly patients.
Stroke risk increased for three months immediately following a shingles diagnosis, with a two-fold risk during the first week.
Herpes zoster, more commonly known as shingles, may occur in anyone previously infected with chicken pox, but is most common in adults 60 years and older due to an age-related decline in immunity.
Patients with shingles who were not treated with antivirals had nearly twice the risk of stroke compared with those who received medication.